Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|November 9, 2022
Extracorporeal photopheresis (ECP) improves overall survival in the treatment of steroid refractory acute graft-versus-host disease (SR aGvHD)Melhem M Solh, Chloe Farnham, Scott R Solomon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 4, 2020
Differences in Graft-versus-Host Disease Characteristics between Haploidentical Transplantation Using Post-Transplantation Cyclophosphamide and Matched Unrelated Donor Transplantation Using Calcineurin InhibitorsMelhem M Solh, Jimena Baron, Xu Zhang, et al.
Bone Marrow Transplantation|September 19, 2019
Real-world outcomes of unselected elderly acute myeloid leukemia patients referred to a leukemia/hematopoietic cell transplant programScott R Solomon, Melhem Solh, Katelin C Jackson, et al.
Bone Marrow Transplantation|January 17, 2018
Long term survival among patients who are disease free at 1-year post allogeneic hematopoietic cell transplantation: a single center analysis of 389 consecutive patientsMelhem M Solh, Asad Bashey, Scott R Solomon, et al.
Blood Advances|March 24, 2023
Improved access to HCT with reduced racial disparities through integration with leukemia care and haploidentical donorsAsad Bashey, Xu Zhang, Lawrence E Morris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 3, 2017
Donor Type and Disease Risk Predict the Success of Allogeneic Hematopoietic Cell Transplantation: A Single-Center Analysis of 613 Adult Hematopoietic Cell Transplantation Recipients Using a Modified Composite EndpointMelhem Solh, Xu Zhang, Katelin Connor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2017
Current Graft-versus-Host Disease-Free, Relapse-Free Survival: A Dynamic Endpoint to Better Define Efficacy after Allogenic TransplantScott R Solomon, Connie Sizemore, Xu Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2016
Factors Predicting Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Hematopoietic Cell Transplantation: Multivariable Analysis from a Single CenterMelhem Solh, Xu Zhang, Katelin Connor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 8, 2019
Who Is a Better Donor for Recipients of Allogeneic Hematopoietic Cell Transplantation: A Young HLA-Mismatched Haploidentical Relative or an Older Fully HLA-Matched Sibling or Unrelated Donor?Eva Karam, Justin Laporte, Scott R Solomon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2016
Impact of Donor Type on Outcome after Allogeneic Hematopoietic Cell Transplantation for Acute LeukemiaScott R Solomon, Connie A Sizemore, Xu Zhang, et al.
Pageof 8